About Endeavor Biomedicines
Endeavor Biomedicines is a private company based in San Diego, California. It has reported $221,703,239 raised in two offerings on Form D since February 2022. Its chief executive is John Hood.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 22, 2024 | May 3, 2024 | $132,583,908fully sold | 32 | $4.1M | EquityRule 506(b) | Form D ↗ |
| Jan 21, 2022 | Feb 7, 2022 | $89,119,331of $100.9M target | 16 | $5.5M | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $221,703,239 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Endeavor Biomedicines's Form D filed May 3, 2024.
PE
Patrick Enright
Director
BD
Bernard Davitian
Director
JH
John Hood
Chief Executive Officer and director
VT
Vishaal Turakhia
Executive officer
CK
Chris Krueger
Executive officer
EK
Enoch Kariuki
Executive officer
KT
Karan Takhar
Director
MR
Miguel de los Rios
Executive officer
MM
Monal Mehta
Director
WL
Wing Lam
Director
Earlier filings also listed Raghu Saripalli (executive officer, last listed Feb 2022).